Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2 - PubMed (original) (raw)

Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2

R Ben-Levy et al. EMBO J. 1995.

Abstract

MAP kinase-activated protein (MAPKAP) kinase-2 is activated in vivo by reactivating kinase (RK), a MAP kinase (MAPK) homologue stimulated by cytokines and cellular stresses. Here we show that in vitro RK phosphorylates human GST-MAPKAP kinase-2 at Thr25 in the proline-rich N-terminal region Thr222 and Ser272 in the catalytic domain and Thr334 in the C-terminal domain. Using novel methodology we demonstrate that activation of MAPKAP kinase-2 requires the phosphorylation of any two of the three residues Thr222, Ser272 and Thr334. Ser9, Thr25, Thr222, Ser272, Thr334 and Thr338 became 32P-labelled in stressed KB cells and labelling was prevented by the specific RK inhibitor SB 203580, establishing that RK phosphorylates Thr25, Thr222, Ser272 and Thr334 in vivo. The 32P-labelling of Thr338 is likely to result from autophosphorylation. GST-MAPKAP kinase-2 lacking the N-terminal domain was inactive, but activated fully when phosphorylated at Thr222, Ser272 and Thr334 by p42 MAPK or RK. In contrast, full-length GST-MAPKAP kinase-2 was phosphorylated at Thr25 (and not activated) by p42 MAPK, suggesting a role for the N-terminal domain in specifying activation by RK in vivo. The mutant Asp222/Asp334 was 20% as active as phosphorylated MAPKAP kinase-2, and this constitutively active form may be useful for studying its physiological roles.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Biol Chem. 1980 Jul 25;255(14):6975-80 - PubMed
    1. FEBS Lett. 1995 May 8;364(2):229-33 - PubMed
    1. Mol Cell Biol. 1985 Dec;5(12):3610-6 - PubMed
    1. Methods Enzymol. 1988;159:390-408 - PubMed
    1. Biochim Biophys Acta. 1990 Feb 19;1051(2):199-202 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources